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ABSTRACT 
 
Background: Visceral leishmaniasis (VL) is caused by Leishmania infantum in Medi-
terranean basin and is an endemic disease in some parts of Iran. Canines are the main 
reservoirs of VL in most of the endemic areas. Different serological methods have been 
introduced for diagnosis of canine visceral leishmaniasis (CVL). Objective: In this sur-
vey a Fucose-Mannose Ligand (FML) ELISA, using native L. infantum antigen, was 
developed and its validity for detection of infected dogs in comparison with direct ag-
glutination test (DAT) and PCR was evaluated. Methods: Blood samples of sixty own-
ership dogs (≤ 3 years old) were collected from Meshkin-shahr district in Ardabil prov-
ince, North-west of Iran. Sera were separated for serological assays (DAT and FML-
ELISA) and the buffy coats were collected for molecular evaluation. Results: Two out 
of the 60 (3.33%) samples were found to be positive (antibody titer of ≥ 1/320) in DAT 
while seven of the 60 (11.66%) samples were positive by FML-ELISA. Nine out of 60 
(15%) buffy coat samples showed a band about 680 bp indicative of L. infantum in 
PCR. Three out of 60 dogs had Kala-azar symptoms and were positive by PCR and 
FML-ELISA, while two of these three dogs had antibody titers >1/320 in their serum 
samples. The sensitivity and specificity of FML-ELISA for the detection of CVL in 
both symptomatic and asymptomatic dogs were found to be 77.8% and 100%, respec-
tively. Conclusion: Considering the acceptable sensitivity and high specificity of FML-
ELISA, use of this serological method can be recommended for epidemiological sur-
veys of CVL. 
 
 
Keywords: Canine, DAT, ELISA, Iran, PCR, Visceral Leishmaniasis  
 
---------------------------------------------------------------------------------------------------------- 
*Corresponding author: Dr. Gholam Reza Hatam, Center for Basic Researches in Infectious Diseases, Shiraz University 
of Medical Sciences, Shiraz, Iran,e-mail: hatamghr@sums.ac.ir 
Mohammadi-Ghalehbin B, et al 
 
Iran.J.Immunol. VOL.8 NO.4 December 2011 245
INTRODUCTION 
 
Visceral leishmaniasis (VL) or kala-azar is an infectious disease caused by L. donovani 
complex and is fatal if left untreated. VL is caused by L. infantum in Mediterranean ba-
sin and is an endemic disease in a few provinces of Iran including Fars province in the 
South, Ardabil and East Azerbaijan provinces in the North-west and in Kohkilooyeh 
and Boyerahmat province in the Southwest of the country (1-5).  
Domestic dogs (Canis familiaris) play the main role as reservoir hosts for human vis-
ceral leishmaniasis (6). Control of reservoirs for visceral leishmaniasis is somehow 
based on the culling of seropositive dogs (7). Common serological methods for epide-
miological studies of canine visceral leishmaniasis (CVL) are indirect immunofluores-
cent antibody test (IFA), enzyme-linked immunosorbent assay (ELISA) and direct ag-
glutination test (DAT). The definite diagnosis of CVL is based on the finding of 
leishmanial amastigotes in biopsy materials from spleen, bone marrow, lymph nodes or 
liver. However such approaches are invasive and have relatively low sensitivity.  High 
validity of DAT can be considered for detection of VL associated with clinical symp-
toms (8). Different studies have confirmed the appropriate performance of DAT for de-
tection of VL and CVL (8-12). 
Although the sensitivity of DAT might be sufficient for detection of asymptomatic in-
fected dogs (13), due to batch to batch variability of DAT antigens, development of a 
sensitive and specific serological method is still required for screening and diagnosis of 
symptomatic and asymptomatic infected reservoirs. 
High sensitivity and specificity of Fucose-Mannose Ligand-ELISA (FML-ELISA) for 
diagnosis of CVL and human visceral leishmaniasis (HVL) has been previously docu-
mented in Brazil (14,15). Here we purified the Fucose-Mannose Ligand (FML) antigen 
from native L. infantum and examined the validity of FML-ELISA in comparison with 
DAT and PCR for detection of CVL.   
 
 
MATERIALS AND METHODS 
 
Study Area and Sample Collection. Blood samples of sixty ownership dogs (≤ 3 years 
old) were collected from Agh-bulagh village in Meshkin-shahr district in Ardabil prov-
ince, North-west of Iran where VL is a major health problem (1,5). Meshkin-shahr is the 
center of Meshkin-shahr County, and is 839 kilometers far from Tehran, the capital of 
Iran. Being near the high Sabalan mountains, it enjoys a moderate mountainous climate. 
Agh-bulagh village is located in south of Meshkin-Shahr city and north of Sabalan high 
mountain. 
All of the dogs were examined for clinical signs such as hair loss, cachexia and dermal 
lesions. The serum of collected blood samples were used for serological assays (DAT 
and ELISA) and the buffy coats were tested by molecular methods. All of the buffy 
coats and serum samples were stored at -20°C until use. 
Direct Agglutination Test (DAT). Antigen for Direct Agglutination Test (DAT) was 
kindly provided by Protozoology Unit of the School of Public Health and Institute of 
Public Health research, Tehran University of Medical Sciences.  
The serum samples from sixty dogs were tested by DAT for detection of anti-
Leishmania antibody. Three dilutions of 1/80, 1/160 and 1/320 were examined for each 
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sample. Positive and negative controls were tested simultaneously in each plate. The 
titer of 1/320 and higher was considered as positive for CVL (5,12). 
FML Antigen Preparation. FML antigen of native L. infantum was prepared as origi-
nally described by Palatnik et al. (16). Briefly, native L. infantum 
(MCAN/IR/07/Moheb-gh) was mass cultivated in BHI broth (37g/l) (Himedia, India) 
supplemented with 10% FCS (Biocera), hemin (0.01g/l) and folic acid (0.02 g/l) 
(Sigma, USA) at 25°C. The promastigotes were harvested after 5-7 days in stationary 
phase and washed three times with PBS. The pellet was mixed with cold distilled water 
and centrifuged and the supernatant was collected. This step was repeated once and the 
two supernatants were mixed and boiled for 15 minutes at 100˚C. The sample was then 
centrifuged and the supernatant was lyophilized for chromatography. The size exclusion 
chromatography was used with 1.6×100 cm column (Pharmacia, USA) and P10 Bio Gel 
(Biorad, UK). FML antigen was collected in void volume, lyophilized and stored at -
20˚C until use.    
Fucose-Mannose Ligand-ELISA (FML-ELISA). ELISA was carried out in flat-
bottom 96-well microplates (Corning, USA). The microplates were coated with 5µg/ml 
of purified FML, diluted in phosphate-buffered saline (PBS), and incubated at 4°C over-
night. Excess antigen was removed by washing with PBS. Blocking was performed with 
blocking buffer [3% skimmed milk in phosphate-buffered saline containing 0.05% 
Tween 20 (PBST)] and the plates were incubated at room temperature for 1.5 hours. 
The plates were washed twice with PBST. 100 µl of diluted sera (1/100 dilution in 
PBST) were added to the plates followed by their incubation at room temperature for 
two hours. After washing with PBST, 100 µl of conjugated anti-dog (HRPO-
conjugated) diluted 1/3000 in PBST was added to each well and the plates were incu-
bated at room temperature for another 1 hour. Plates were then washed with PBST, in-
cubated with 100 µl of substrate solution (Ortho phenylenediamine, 100mg in 250ml 
citrate phosphate buffer and 125 µl hydrogen peroxide) at room temperature for 30 
minutes. The optical density was determined at 490 nm (OD490) using an ELISA plate 
reader. The cut off point was set as 3SD above the mean of control samples. 
DNA Extraction. DNA was extracted from buffy coat samples of 60 dogs as described 
previously (17). Briefly, 50 μl of buffy coat and 150 μl of lysis buffer (Tris base, 
EDTA, Tween 20; pH=8) was mixed with 5 μl of proteinase K and incubated at 37°C 
for 24 hours. Then 75 μl of phenol: chloroform: isoamyl alcohol was added and mixed 
well. The sample was centrifuged at 15000 ×g for 10 minutes. Aqueous top phase was 
removed and absolute alcohol was used to precipitate the DNA.  
kDNA Amplification by Nested PCR. Amplification of the kDNA of Leishmania was 
performed using a two-step nested PCR as originally described by Noyes et al. (18). The 
external primer pair, CSB2XF (C/ GA/GTA/ GCAGAAAC/ TCCCGTTCA) and 
CSB1XR (ATTTTTCG/ CGA/TTTT/ CGCAGA ACG) were used for the first-round of 
PCR amplification and the internal primer pair, 13Z 
(ACTGGGGGTTGGTGTAAAATAG) and LiR (TCGCAGAACGCCCCT) were used 
for the second-round of PCR amplification.  
Electrophoresis of PCR Products. PCR products were electrophoresed on 1.5% aga-
rose gel and positive samples were compared with DNA ladder for identification of 
Leishmania spp. In this nested PCR method, the size of PCR products varies in different 
species of Leishmania. It is 560 bp for L. major, 680 bp for L. infantum and 750 bp for 
L. tropica (18). 
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RESULTS 
 
Antibodies to L. infantum (titer ≥ 1/320) were detected in serum samples of two out of 
60 (3.33%) dogs by DAT. Both animals had cachexia and hair loss and one had dermal 
wounds as well. Moreover, one of the samples had antibody titer of 1/160 in DAT and 
this was the sample from a symptomatic dog with cachexia, hair loss and dermal 
wounds. Furthermore, six of animals had antibody titer of 1/80 but they were all asymp-
tomatic. No antibody was detected in the rest of 51 animals and none of these animals 
had any symptoms of CVL. 
When the samples were tested by FML-ELISA, seven out of 60 (11.6%) serum samples 
were positive by this assay. A sensitivity of 77.8% (95% CI=40.2%-96.05%) and a 
specificity of 100% (95% CI=91.3%-100%) were calculated for the FML-ELISA in 
comparison to PCR, as the golden standard. Positive predictive value (PPV) and nega-
tive predictive value (NPV) of the test were 100% (95% CI=56.1%-100%) and 96.2% 
(95% CI=85.9%-99.3%), respectively. Three of these seropositive dogs were sympto-
matic while the rest (four dogs) had no symptoms related to CVL upon clinical exami-
nation. Two of these seven seropositive dogs had antibody titers of ≥ 1/320 by DAT and 
one had serum antibody level of 1/160.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Leishmania minicircle kDNA amplification by nested PCR in dogs buffy coat samples. 
The size of PCR products varies in different species of Leishmania by this method. It is 560 bp 
for L. major, 680 bp for L. infantum and 750 bp for L. tropica. lane 1; L. major (control), lane 2; L. 
infantum (control), lane 3 and 4; L. infantum from infected dogs, lane 5; 100 bp ladder and lane 
6; negative control. 
 
 
All of the seven FML-ELISA positive samples were positive by PCR. When the buffy 
coat samples of the animals were tested by PCR, a 680 bp fragment corresponding to L. 
infantum was detected in nine out of 60 (15%) samples (Figure 1). Seven out of nine 
(77.7%)  PCR-positive samples were positive by FML-ELISA while only two of them 
(22.2%) were found to be positive by DAT. Besides, six of PCR-positive dogs had no 
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CVL-related symptoms. Table 1 summarizes the performance of FML-ELISA, DAT 
and PCR in the diagnosis of symptomatic and asymptomatic CVL. 
 
 
Table 1. Comparison of FML-ELISA, DAT and PCR in diagnosis of CVL in symp-
tomatic and asymptomatic dogs. 
 
Methods 
 
Samples 
Symptomatic dogs 
3(5%) 
Asymptomatic dogs 
57(95%) 
Total  
     60 (100%)     
Positive   
 n (%) 
Negative   
 n (%) 
Positive  
 n (%) 
Negative   
n (%) 
FML-ELISA 3 (100) 0 (0) 4 (7.02) 53 (92.98) 60 (100) 
DAT 2 (66.67) 1 (33.33) 0 (0) 57 (100) 60 (100) 
PCR 3 (100) 0 (0) 6 (10.53) 51 (89.47) 60 (100) 
 
 
DISCUSSION 
 
FML-ELISA has been used for diagnosis of human visceral leishmaniasis in Brazil and 
has showed 100% sensitivity and 96% specificity for identifying patients with overt 
Kala-azar (15). It has also been reported that FML-ELISA could identify subclinical VL 
infections (15). The same group used FML-ELISA for detection of canine visceral 
leishmaniasis in Brazil with a sensitivity and specificity of 100%. The assay could also 
identify the asymptomatic dogs, with 100% predictive value (15).  
In this study we prepared FML antigen from native L. infantum and evaluated the per-
formance of FML-ELISA for detection of VL-infected dogs in Meshkin-shahr, an area 
in the Northwest of Iran which is known as one of the main foci of VL. Seven out of 60 
ownership dogs were FML-ELISA positive in this study whereas only three of the dogs 
had clinical signs. On the other hand, four out of seven FML-ELISA positive dogs were 
asymptomatic. These findings are in agreement with the results of Borja Cabrera et al. 
(15) study in Brazil. We compared the results of our FML-ELISA with DAT and PCR 
and found that FML-ELISA is a suitable assay for detection of CVL in both sympto-
matic and asymptomatic dogs. Performance of serological methods, such as DAT and 
IFA, for identification of VL and CVL has been evaluated in several studies. Zijlstra et 
al. reported a sensitivity of 94% and specificity of 72% for DAT in comparison with 
tissue direct microscopy for diagnosis of Kala-azar (19). In a study by Mikaeili et al. 
(20), sensitivity and specificity of three serological methods for detection of anti-
Leishmania antibodies in VL patient were found to be 70.5% and 100% for DAT, 
83.6% and 90.5% for ELISA, and 80.3% and 90.5% for IFA, respectively. In a similar 
study, Sarkari et al. (21) have reported a sensitivity and a specificity of 83.6% and 
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90.5% for ELISA and 70.5% and 100% for DAT, respectively. Similar results for 
ELISA (sensitivity = 86.2%, specificity = 90.5%) and DAT (sensitivity = 93.1%, speci-
ficity = 100%) were reported by Ghatei et al. (22). Sera samples from parasitologically 
confirmed VL patients have been used in all of the aforementioned studies. 
Performance of DAT for detection of L. infantum infection in dogs has been assessed in 
few studies. Mohebali et al. found a sensitivity of 70.9% and a specificity of 84.9% at a 
1/320 cut off point for detection of anti-Leishmania antibody in dogs (11). In another 
study in Sudan, sensitivity of 100% and specificity of 98.9% have been reported for 
DAT in the diagnosis of CVL (9).  
Recent molecular studies on the diagnosis of CVL showed considerable discrepancies 
between the results of serological and molecular methods (13,23,24). In the study of 
Moshfe et al. which has been performed in the same area as our study, sixteen out of 66 
symptomatic and asymptomatic dogs were reported to be positive by DAT whereas 37 
of them were found to be positive by PCR (13). Our findings are in agreement with pre-
vious studies (13,23,24,25) which show that molecular methods have higher sensitivity 
for diagnosis of symptomatic and asymptomatic infection in dogs. In the study of Mosh-
fea et al. DAT has not been able to detect all of the asymptomatic infected dogs (13). 
Asymptomatic dogs, as reservoirs, can play an important role in the epidemiology of 
human and canine VL (26). 
Considering the results of this study, the performance of the FML-ELISA for the detec-
tion of CVL in both symptomatic and asymptomatic dogs is significant. Seven out of 
nine PCR-positive dogs were positive by FML-ELISA and all of the FML-ELISA posi-
tive samples were positive by PCR. Considering PCR as a gold standard method, sensi-
tivity and specificity of present FML-ELISA for the detection of CVL in both sympto-
matic and asymptomatic dogs would be 77.8% and 100%, respectively. It should be 
noted that PCR can detect both infection and the disease in the animals. Therefore PCR 
might not be a suitable gold standard method for diagnosis of CVL. Other serological 
methods are unable to detect the infected dogs in the early stages and may show low 
sensitivity and specificity if PCR is considered as a gold standard and that is what we 
are seeing in our study.  
In view of the high diagnostic performance of FML-ELISA, this serological method can 
be recommended for epidemiological surveys of CVL in any VL endemic areas, espe-
cially in Iran. Further studies are needed for proper evaluation of FML-ELISA in com-
parison with other serological and parasitological assays for the diagnosis of human VL 
and also CVL in our country.   
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